BAK1
Bcl-2 homologous antagonist/killer
Also known as: BAK, BAK_HUMAN, BCL2L7, CDN1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16611
- Gene
- BAK1
- Ensembl
- ENSG00000030110
- Chromosome
- 6
- Canonical length
- 211 aa
- Protein class
- Predicted membrane proteins, Transporters
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene belongs to the BCL2 protein family. BCL2 family members form oligomers or heterodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. This protein localizes to mitochondria, and functions to induce apoptosis. It interacts with and accelerates the opening of the mitochondrial voltage-dependent anion channel, which leads to a loss in membrane potential and the release of cytochrome c. This protein also interacts with the tumor suppressor P53 after exposure to cell stress. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
211 residues, UniProt reviewed canonical sequence.
>Q16611|BAK1
1 MASGQGPGPP RQECGEPALP SASEEQVAQD TEEVFRSYVF YRHQQEQEAE GVAAPADPEM
61 VTLPLQPSST MGQVGRQLAI IGDDINRRYD SEFQTMLQHL QPTAENAYEY FTKIATSLFE
121 SGINWGRVVA LLGFGYRLAL HVYQHGLTGF LGQVTRFVVD FMLHHCIARW IAQRGGWVAA
181 LNLGNGPILN VLVVLGVVLL GQFVVRRFFK SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BAK1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 44 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 44 nTPM
- small intestine: 35 nTPM
- esophagus: 32 nTPM
- colon: 30 nTPM
- spleen: 29 nTPM
- adrenal gland: 28 nTPM
Single-cell type
- megakaryocytes: 62 nCPM
- enterocytes: 55 nCPM
- colonocytes: 44 nCPM
- esophageal basal cells: 41 nCPM
- esophageal suprabasal cells: 40 nCPM
- extravillous trophoblasts: 40 nCPM
Immune cell
- eosinophil: 85 nTPM
- intermediate monocyte: 65 nTPM
- basophil: 64 nTPM
- non-classical monocyte: 57 nTPM
- T-reg: 56 nTPM
- total PBMC: 53 nTPM
Brain region
- choroid plexus: 15 nTPM
- thalamus: 14 nTPM
- medulla oblongata: 14 nTPM
- pons: 13 nTPM
- spinal cord: 13 nTPM
- cerebral cortex: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.37
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.99
- DepMap mean gene effect
- -0.37
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- animal organ regeneration
- apoptotic process
- apoptotic process involved in blood vessel morphogenesis
- apoptotic signaling pathway
- B cell apoptotic process
- B cell homeostasis
- B cell negative selection
- blood vessel remodeling
- calcium ion transport into cytosol
- cellular response to mechanical stimulus
- cellular response to unfolded protein
- cellular response to UV
- endocrine pancreas development
- endoplasmic reticulum calcium ion homeostasis
- epithelial cell proliferation
- establishment or maintenance of transmembrane electrochemical gradient
- extrinsic apoptotic signaling pathway in absence of ligand
- fibroblast apoptotic process
- intrinsic apoptotic signaling pathway
- intrinsic apoptotic signaling pathway in response to DNA damage
- intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
- limb morphogenesis
- mitochondrial fusion
- myeloid cell homeostasis
- negative regulation of cell population proliferation
- negative regulation of endoplasmic reticulum calcium ion concentration
- negative regulation of gene expression
- negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
- negative regulation of release of cytochrome c from mitochondria
- positive regulation of apoptotic process
- positive regulation of calcium ion transport into cytosol
- positive regulation of IRE1-mediated unfolded protein response
- positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
- positive regulation of protein-containing complex assembly
- positive regulation of proteolysis
- positive regulation of release of cytochrome c from mitochondria
- post-embryonic camera-type eye morphogenesis
- regulation of cell cycle
- regulation of mitochondrial membrane permeability
- regulation of mitochondrial membrane potential
- release of cytochrome c from mitochondria
- response to ethanol
- response to fungus
- response to gamma radiation
- response to hydrogen peroxide
- response to mycotoxin
- response to UV-C
- response to xenobiotic stimulus
- thymocyte apoptotic process
- vagina development
Molecular functions
- BH domain binding
- channel activity
- heat shock protein binding
- identical protein binding
- metal ion binding
- porin activity
- protein heterodimerization activity
- protein homodimerization activity
- protein-containing complex binding
- protein-folding chaperone binding
- transmembrane transporter binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BAK1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BAK1 as an antibody target. Whether an autoantibody or antibody against BAK1 could matter depends on whether native BAK1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BAK1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BAK1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...